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1. Introduction
Tissue investigation remains one of the most reliable diagnostic ways in both general medical
practice and liver pathology. At present, the routine liver biopsy investigation should include
obtaining a representative tissue sample, adequate technological processing and application
of histochemical stain panel [1-5]. The evaluation must be done in accordance with up-to-date
disease classifications and validated diagnostic criteria [6]. Protocol approach is recommend‐
ed in order to decrease the variability in description. In case of chronic inflammatory liver dis‐
ease, semiquantitative evaluation of inflammatory activity by Knodell, Ishak, METAVIR or
Scheuer score, or analogous system [7-11] must be applied. Additional methods as immuno‐
histochemistry or polymerase chain reaction are applied by necessity. The morphological
evaluation of biopsy is a part of medical teamwork. It should be preceded by clinical and lab‐
oratory investigations and biopsy findings must be incorporated in the general patient’s in‐
formation. Many of these principles will remain in use in the nearest future. However, both
clinical diagnostics and medical research undergo almost unlimited progress. The upcoming
innovations in liver biopsy analysis include incorporation of digital image analysis, genetic
investigations and immunohistochemistry for functionally important molecules as cytokines,
cell cycle markers and viral life cycle markers into everyday practice.
2. Morphological evaluation of liver: Today’s reality
Despite the fact that the histological assessment of liver tissues plays an essential role in the
diagnosis of liver diseases and the histological conclusion serves quite often as a basis for
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establishing the diagnosis, there are factors or reasons to be taken into consideration which
can negatively influence the results obtained in morphological evaluation of liver biopsy.
We have "assessed" the percentage of each factor’s influence on the final result– description
and conclusion regarding diagnosis, where "0" is considered a factor that does not affect the
evaluation and its outcome, but "100%” – the factor which actually hinders the correct diag‐
nosis of the disease. The factors that may affect the liver tissue morphological assessment
and diagnosis of disease are summarized in Table 1.
No. Factors affecting liver tissue
morphologic assessment
Evaluation of impact on
final outcome in % *
Comments
1. Biopsy site selection in liver tissues 100 – 0 It can be completely non-representative site, such as subcapsular
2. Fixation and transfer of biopsy sample 100 – 0
Chemical environment (composition)
and temperature of fixation can affect
the biopsy specimen
3. Selection of certain section out of thewhole sample 50 – 0
If the whole sample is used, then the
error theoretically is not possible
4. Selection and quality of staining (panel ofvisualization methods) of the sample 100 – 0
If the sample is not stained for the
reason to label a certain substance,
e.g., Fe, the error can reach 100%
5. Quality of biopsy specimen sections ormicrotomy 30 – 0
Thick or disrupted tissue sections can
hinder the pathology from the
observer. The thickness should not
exceed 3-4 micrometres.
6. Number of viewable visual fields 80 – 0 Inaccuracies can occur if only someseparate visual fields are examined
7. Technical condition of the microscope 80 – 0
Incomplete quality of optical system
can hinder the pathology from the
observer.
8. Selection of evaluation scale 100 – 0
If the specimen where the basic
pathology relates to fatty changes
(steatosis) is assessed according to
Knodell scale, then the assessment is
inadequate if compared to the actual
liver tissue damage
* 100% - affecting
0% - not affecting
Table 1. Factors affecting liver tissue morphologic assessment
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Further we will have a look at each factor separately. The first reason which may significant‐
ly affect the final result is the incidental character of biopsy specimen collection by means of
“blind” biopsy. In case of diffuse liver damage, it is important to obtain liver specimen from
a representative site (which is not subcapsular) or under ultrasonographic (USG) control. If
the liver specimen is obtained during invasive procedure (laparoscopy or open abdominal
surgery), it is of high importance to give information about preferable biopsy site to the col‐
league obtaining liver specimen. The liver specimens obtained during surgery are certainly
more targeted. More or less qualitative methodological performance of tissue collection may
also cause certain imperfections affecting quality of specimen evaluation.
Presuming that the biopsy specimen is obtained from the site typical for the certain liver
pathology, one more important issue is the quality of biopsy specimens’ fixation and slicing.
The aspect of „special” tissue staining must also be looked at, because in case of absence of
examination request or list of preliminary diagnosis provided by clinician, that emphasizes
the need for particular staining, morphologist is unable to give an adequate diagnostic as‐
sessment of biopsy specimen. Thus diagnosis like haemochromatosis and other pathologies
known as "storage diseases" can be missed.
The next factor, i.e., selection of certain section out of the whole biopsy specimen, is an issue
arising only in case if the biopsy specimen is not examined throughout or along its horizon‐
tal length. The cross-sectioning gives the chance to analyze tissues on different "depths" or
„levels” of the biopsy specimen.
The technical condition or quality of the microscope and number of viewable visual fields are
to be considered seriously. Nowadays, the usual practice of the pathologist is a general over‐
view of the material to gain insight into overall picture, noticing the most typical and impor‐
tant peculiarities. Inaccuracies can occur if only some separate visual fields are examined.
The subjective component of the morphological assessment of liver specimens and interpre‐
tation of the observed changes and their compliance or adherence to one or the other pathol‐
ogy is essential also. The problem could be the qualification and experience of clinician to
put together or combine visual insight in the particular biopsy specimen and clinical diagno‐
sis made up of biochemical, immunological and genetic parameters, and to use the interpre‐
tation of morphologist properly for establishing the diagnosis.
Selection of morphological or histological evaluation scale is significant. These scales are
very advantageous for standardizing expert’s assessment, converting it into measurable
characteristics and helping the clinician to make final decision about patient’s diagnosis. In
case of light microscopy the issue of selection of evaluation scale is a factor with up to 100%
error probability. For example, the use of the Knodell scale for patient with steatohepatosis,
HAI = 0, leads to incorrect conclusion that the patient is healthy, especially if the biochemi‐
cal parameters of blood are not altered.
If in addition the electron microscopic investigation of sequential liver biopsy specimens are
done, obtained results and conclusions are also affected by the whole process of the above men‐
tioned biopsy specimen collection and processing. The electron microscopy is currently consid‐
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ered as an auxiliary method or technique, yet in the age of high-tech medicine, processes
ongoing on the level of organelles are the ones which by characteristic ultrastructural changes
frequently refer to or indicate a particular pathology. The following must be strictly observed in
electron microscopy: 1) liver tissue sampling and slicing into 1 mm3 pieces without mechanical‐
ly squeezing them and immediate immersion in fixing solution; 2) chemical composition of fix‐
ing solution, temperature, sample fixation and rinsing time; 3) embedding of liver tissue
samples in mixture of epoxy resins in accordance with polymerization time of these resins; 4)
quality of sample cutting with ultramicrotome and contrasting with uranyl acetate and lead cit‐
rate; 5) all cells and their organelles visible in the ultra-thin slices under the electron microscope
have to be examined. It should be noted that resolution of transmission electron microscope
(TEM) is within the range of 0.2 to 2 nm and resolution of scanning electron microscope is 4 nm.
3. Virtual microscopy: The general principles
To reduce the potential inaccuracies in the processing and evaluation of biopsy specimens it
is important to look for modern solutions in order to maximize the efficiency of use of biop‐
sy specimens. One of the solutions could be application of virtual microscopy having exten‐
sive mathematical basis with fractal and entropy considerations as well as technological
support by appropriate software and hardware. Implementation of innovations into practice
could significantly increase the effectiveness of liver biopsy specimens.
The digital image analysis [12-14] and computed morphometry in general is considered an
important tool in pathology. It can decrease the workload of voluminous repeated measure‐
ments and increase the accuracy and objectiveness of the results. In several fields, e.g., im‐
munohistochemical and molecular typing of breast cancer, the application of digital image
analysis is already highly practical [13].
In virtual microscopy, the demands for mathematical basis are higher than in routine histol‐
ogy. This is illustrated by examples of entropy considerations, Delaunay’s triangulation or
fractal geometry and general non-Euclidean geometry for irregularly shaped biological ob‐
jects [14-16]. Sophisticated software must be elaborated as well. Additional technical re‐
quirements exist for image resolution and size, fast wide-band data transfer as well as
digital data storing [12, 13]. The slide scanners and visualisation software are available and
improve continuously [12].
Computed morphometry becomes more practical in association with virtual microscopy and
digital image analysis as well. As postulated in reference [16] the natural development of
science occurs from the ability to recognize, name and classify the object (corresponding to
the diagnosis, e.g., chronic viral hepatitis C) to semiquantitative, ordering measurements
(e.g., the activity assessment by Knodell or any analogous scale), finally reaching quantita‐
tive characteristics. Descriptive diagnoses and semiquantitative estimates are widely used in
the „classic” liver pathology. In order to gain sufficient reliability and fastness, scalar meas‐
urements would require digital assessment [16]. Computed morphometry on the basis of
virtual microscopy is a way towards scalar measurements.
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The virtual microscopy can be performed in two different ways. Interactive virtual micro‐
scopy by whole slide imaging leaves the conclusion in the hands of pathologist. It changes
significantly the working tools from optical microscopy and subjective decisions to comput‐
er screen and objective measurements. The automated virtual microscopy is even more ex‐
citing as computer system should evaluate the diagnoses [14].
In liver pathology, the software develops regarding assessment of steatosis [17-19] and fib‐
rosis [20-24]. Necroinflammatory changes can be quantified as well [16].
Regarding liver ultrastructure, morphometric evaluation of hepatocyte volume can have
prognostic significance predicting survival as shown in liver cirrhosis associated with portal
hypertension [25]. Morphometric analysis of liver parenchyma in different alcohol-related
pathologic conditions has been tested with good results [26]. Thus, changes in the volume
fraction of parenchymal interstitial space and in the surface density of hepatocyte plasma
membrane, rough endoplasmic reticulum and outer mitochondrial membrane can be of im‐
portance for distinguishing between cirrhosis and non-cirrhotic states. Hepatocyte nuclear
volume fraction measurement can predict the survival in case of cirrhosis. Interestingly, few
images are necessary to perform these measurements thus helping to characterise even
scarce tissue material [26].
Combination of multiplex quantum dot immunostaining with high resolution whole-slide
digital imaging and automated image analysis has been described [27].
At present, the two most frequently studied targets for computer-assisted and/or digital im‐
age analysis in liver biopsies include steatosis and fibrosis.
4. Digital assessment of liver steatosis
Among Western population, liver steatosis is a frequent finding [28-29] as it is associated
with such common factors as chronic viral hepatitis [19], alcohol drinking, diabetes mellitus
or obesity [17]. It has been considered a risk factor for liver fibrosis [18, 19]. Steatosis, includ‐
ing non-alcoholic steatohepatitis [19] has become an important target in diagnostics and sci‐
entific research therefore highly reproducible measurements are necessary to evaluate the
course of disease, outcome and effect of treatment. The biopsy is still considered a gold
standard in the diagnosis and assessment of steatosis as the imaging including ultrasonogra‐
phy, computed tomography and magnetic resonance imaging can be affected by lower sen‐
sitivity [17, 30]. The severity of steatosis in liver biopsies can be graded by several semi-
quantitative systems (Table 2) assessing the eyeballed proportion of affected cells [30-35].
The present semiquantitative estimates are subjective and limit the possibilities of statistic
analysis [18]. Numerical value, expressing the exact percentage of affected cells would be
more reliable if an adequate biopsy is analysed. Such measurement is possible, especially in
computer-assisted way, but it would require architecturally arranged count of nuclei and fat
vacuoles per biopsy. Thus, the measurement would be time-consuming and accordingly ex‐
pensive. On the other hand, steatosis is relatively easy target for digital quantification of the
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general fat amount due to the regular shape and distinct colour of fat vacuoles [18, 19]. The
digital quantification of steatosis shows high reproducibility exceeding the quality of man‐
ual estimate [19]. Commercial software for image analysis has been recently employed and
novel automated procedures are under development [18]. The estimate is more reliable if
both morphological and chromatic operators are used in order to characterise lipid particles
[18]. The fat vacuole is optically and geometrically simple object – optically empty after rou‐
tine processing and deparaffinisation, thus white and rounded. If colour only is used for
identification, however, the sinusoids, empty portal vessels and bile ducts [30] as well as
glycogen nuclei in hepatocytes might be undertaken as false positives (Figure 1). The round‐
ed shape of fat vacuole helps to exclude longitudinal or tangential sections of sinusoids,
blood vessels and portal bile ducts. In haematoxylin-eosin stained sections, the colour con‐
trast can be used to identify glycogen nuclei as in this case the optically empty space is sur‐
rounded by basophilic nuclear membrane in contrast to fat vacuole located in eosinophilic
cytoplasm. Thus, the conclusion at present is to include both chromatic, size and shape as‐
sessment [18, 30]. Manual check can improve the accuracy in case of perpendicular sections
of small vessels and fat cysts [30]. However, such control would increase the workload. The
benefits of objectiveness and numerical value of continuous variable still remain. More stud‐
ies would be necessary to determine how accurate the control must be for practical means;
theoretically the significant vascular changes in cirrhosis point towards the idea that accu‐
rate identification of fat vacuoles is a must to avoid non-random errors.
Grading Reference
Mild: less than 30% hepatocytes involved
Moderate: 30-60% hepatocytes involved
Severe: more than 60% hepatocytes involved
[31]
Grade 0 (no or minimal steatosis): less than 5% hepatocytes involved
Grade 1: at least 5% but less than 25% hepatocytes involved
Grade 2: at least 25% but less than 50% hepatocytes involved
Grade 3: at least 50% but less than 75% hepatocytes involved
Grade 4: at least 75% hepatocytes involved
[32]
Estimating the percentage of affected hepatocytes in 5% bands [30]
Grade 0: less than 1%
Grade 1: at least 1% but less than 6% hepatocytes involved
Grade 2: at least 6% but less than 34% hepatocytes involved
Grade 3: at least 34% but less than 67% hepatocytes involved
Grade 4: at least 67% hepatocytes involved
[34]
[35]
Grade 1: less than 33%
Grade 2: at least 33% but less than 66% hepatocytes involved
Grade 3: more than 66% hepatocytes involved
[33]
Table 2. The different grading systems of liver steatosis
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Figure 1. Liver steatosis. Note the macrovesicular steatosis (stars) characterised by size of fat vacuole exceeding the
diameter of hepatocyte nucleus, and the microvesicular steatosis (small arrows) caused by fat vacuoles smaller than
hepatocyte nucleus. The optically empty fat vacuoles must be promptly distinguished from glycogen nuclei (large ar‐
row) and sinusoids (arrowhead). Haematoxylin-eosin stain, original magnification 400x
The fat stains as Sudan IV are well-known [4]. However, several researchers have reported tech‐
nical problems. The artifacts can include deformation of lipid vacuoles as well as sinusoidal and
background staining [17, 36-38]. The non-lipid positivity would limit the possibilities of colour
analysis, and the deformation – of shape analysis. The practicality of osmium tetroxide stain is
negatively affected by the necessity to use frozen tissue and by the toxicity of reagents [4].
Several research groups have reported that manual assessment of steatosis leads to signifi‐
cantly higher estimates than computer-obtained data [17, 19] regardless if area measurement
or stereological point counting is used [30]. The coefficient can be as high as 3.78 [19]. Practi‐
cising physicians should remember that association between degree of steatosis and risk of
cirrhosis is proved using manual assessments and thus the scales are adjusted for manual
use. Consequently, interpretation of digital data cannot involve the use of unadjusted previ‐
ous scales as risk classes.
It should be noted that the principal meaning of diagnosing steatosis is not affected by the
evaluation method. Increasing steatosis percent is associated with advancing fibrosis stage
both manually and digitally [19]. The data obtained by pathologist and automated software
show close correlation [17]. After liver transplantation, aspartate aminotransferase, alanine
aminotransferase and prothrombin time have shown better correlation with automated
measurements in 4 of 5 posttransplant time points but the total bilirubin level correlated bet‐
ter with manual assessment in 3 of 5 time points. The graft survival showed a significant as‐
sociation with macrovesicular steatosis both in automated and manual measurements
although the p value was less for automated measurement [17].
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When analysing liver steatosis, the observations of higher accuracy in resin-embedded sam‐
ples [18] request more technological progress in order to create methodology for easy use in
routine samples.
Digital stereological point counting has been employed in liver steatosis evaluation as well
[33]. The researchers have observed the same fact that manual semiquantitative assessment
tends to be significantly higher. The lack of precision in manual evaluation can be related to
the physiology of vision and processing of the visual information [19, 39].
Some researchers have also come to the conclusion that automated assessment of liver stea‐
tosis is more time-consuming than manual [30]. The time input for digital measurement is
found to be threefold greater than for manual evaluation [19]. Although this opinion is
based on trustable experience, half of the problem is solved already as the whole slide imag‐
ing eliminates the need to choose appropriate number of representative fields submitted for
analysis and the necessity for human participation in the obtaining and archiving of digital
images. Besides the whole slide imaging, the degree of automatisation must be further in‐
creased: optimal software abolishes the manual correction of object inclusion into measure‐
ments. However, this deserves morphologically correct mathematical model. Other groups
have considered computer-aided morphometry to be fast and objective [16].
5. Digital assessment of inflammation in liver biopsy
The computer-aided assessment of necroinflammatory processes in chronic viral hepatitis has
been tested. To perform this, immunohistochemical visualisation is necessary in order to high‐
light inflammatory cells. The application of immunohistochemistry increases the expenses.
This drawback can be counterbalanced by gains of rapid measurement, resulting in rigorous
results expressed in scalar numbers as well as by complete characteristics more exactly reflect‐
ing the status of the whole organ [16].
The assessment of hepatic fibrosis and the closely related architectural deformities as bridging
fibrosis and liver cirrhosis have important role in the diagnostics, treatment and prognostic
evaluation of chronic liver diseases [24]. The studies of liver fibrosis are facilitated by standard
use of special stains for the routine evaluation of liver biopsies in case of diffuse liver disease.
Masson’s trichrome is an efficient method to highlight fibrosis [3]. The sharp contrast between
blue collagen and red parenchyma allows visualisation of even small excess amounts of colla‐
gen [23]. Sirius red stain has also been employed [21, 40]; it has the benefit of selective staining
of collagen but not proteoglycans [22]. Not surprisingly, comparatively many authors have ap‐
plied digital image analysis to quantify fibrosis in liver tissue [24]. Validation studies of com‐
puter-assisted  morphometry  have  also  been performed [21].  Besides  the  well-developed
methodology including software, the application of computer analysis has resulted in exact
numerical data allowing detection of interesting biological relationships. For instance, the cor‐
relation of fibrosis burden with end-stage liver disease score, serum total bilirubin and interna‐
tional standard ratio of prothrombin has been shown in hepatitis B-related decompensated
cirrhosis. Thus, the correlation between the amount of connective tissue in cirrhotic liver and
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hepatic functional reserve was demonstrated [24]. The problem was insufficient accuracy of
computer-assisted morphometry [21] manifesting as inter-observer differences. Poor correla‐
tion of the fibrosis area with Ishak staging score has been observed as well [21]. Other scientists
have also found that analysis of early fibrosis necessities qualitative assessment despite the
general correlation between amount of connective tissue and Ishak grade of fibrosis [20]. Tis‐
sue geometry differences in subsequent sections also can be more accurately classified by hu‐
man eye [22]. Full section digital analysis seems to be important [20].
Digital image analysis for the evaluation of fibrosis in chronic viral hepatitis C has been
studied also as mentioned in references [41-42]. Automatic quantification of liver fibrosis in‐
cluding the validation of the method has been performed as described in reference [43]. Oth‐
er investigators have employed computerised image analysis for the evaluation of fibrosis as
well [44-47]. In most investigations, correlation between digital and manual semiquantita‐
tive score has been shown [20, 44-47]. However, the digital data do not allow to differentiate
between low stages of fibrosis [20, 45, 47].
6. Digital biopsy analysis for inflammatory liver lesion: Future begins
today
The incorporation of Mandelbrot’s fractal geometry [48] into the digital evaluation of liver
biopsy for chronic hepatitis has brought revolutionary changes [40].
The short description of fractal is provided in Table 3; detailed characteristics can be found
in recent reviews [49].
Definition and essential
features of fractal
The fractal is a mathematical object characterised by self-similar patterns. At every scale,
fractal shows (infinitely) either the same structure or is at least similar to other scales. The
complexity is retained independently of magnification. Thus, although fractal curve is one
dimensional similarly to regular line, the fractal dimension is greater than topological
dimension. Due to the infinite similarity, fractals cannot be measured in traditional ways.
Although fractals have got significant popularity due to their beauty, the importance of
fractal theory is in the mathematical basis and the ability to describe, among other
processes, the biological phenomena.
Fractals in nature: selected
examples
Beds of rivers, irregularity of coastline, profiles of mountain chain, clouds
Fractals in biology: selected
examples
Branching of blood vessels or bronchi, the invasive edge of tumour, neurons. See also Figure 2-6
Peculiarities of fractals in
biology
Biological fractal-like objects have limited range of self-similarity upon magnification thus
behaving as random fractals, in contrast to mathematical/geomaterical constructs with unlimited
level of complexity (self-exact fractals)
Table 3. The characteristics of fractals
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Figure 2. Highly irregular structure of biological object. Use of Mandelbrot’s fractal geometry is suggested to describe
targets with remarkable degree of complexity and irregularity. Note also the similarity of complex, branching outline
with Figures 4 and 5
Figure 3. Retained irregularity of the biological structure at higher magnification: note the remarkable similarity with
Figure 2. The persisting complexity at different levels of magnification is another feature suggesting the necessity for
fractal analysis. The inflammation in liver biopsy (shown in Figures 4 and 5) depicts analogous features
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Hurst’s exponent is another albeit related mathematical construct with major meaning in the
digital analysis of liver biopsy. It was first used to study the variation in water flow in Nile ba‐
sin during the construction of the Aswan dam [16, 50]. In general, it can be used to detect the ir‐
regularity – a key parameter analysing the activity of inflammation in the liver as the active
inflammation manifests with periportal piecemeal necrosis causing irregularity in the normal‐
ly smooth border of portal field. Hurst’s exponent also can be detected by fractal mathematics.
It can describe quantitatively the deviation from smooth contour in natural fractal objects.
To detect the border of inflammatory cell cluster, Delaunay’s triangulation can be used with
success. In general, Delaunay’s triangulation involves set of points in such way that no point is
inside the circle drawn through 3 points. It maximizes the minimum angle avoiding narrow
triangles. If circle drawn through 2 input points contain the third point in the outside, these
points form Delaunay’s triangle. The method can be used to mesh the space. By this triangula‐
tion, lines were drawn in the scanned image of liver biopsy through each pair of adjacent in‐
flammatory cells resulting in network of triangles showing common border. The most external
triangle short sides formed the border of inflammatory cell infiltrate. The triangle side was de‐
fined as appropriately short if it was equal of less than 20 microns based on empiric analysis.
After the cluster has been outlined, both the amount (by area) of inflammatory cells and the
border irregularity and area of cluster-affected tissue can be evaluated [16].
The mathematical basis of so-called geometry of irregularity (Figure 2-3) has allowed to detect
the amount of residual liver parenchyma, inflammation (Figure 4-5) and fibrosis (Figure 6-7) as
well as to provide index characterising the appropriateness of liver tissue structure (named tec‐
tonic index by the authors).
Figure 4. Irregular outline (arrowheads) of portal field in chronic active hepatitis. Haematoxylin-eosin stain, original
magnification 100x
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Figure 5. Branching pattern (arrowheads) of periportal inflammatory infiltrate. Note the remarkable similarity with
Figure 4 analogous to the relationship between Figures 2-3. The fractal nature of inflammation is thus highlighted.
Haematoxylin-eosin stain, original magnification 400x
Figure 6. Branching outline of connective tissue fields in liver cirrhosis. Note both the large areas of connective tissue
(star) and the thin septa (arrowheads). Masson’s trichrome stain, original magnification 100x
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Figure 7. Branching pattern of connective tissue fields in arachnoid liver fibrosis (arrowhead). Masson’s trichrome
stain, original magnification 400x
The Dioguardi  Histological  Metriser  machine,  described in reference [40]  is  able to pro‐
duce measurements and even simple diagnoses, working with reasonable speed. The rel‐
evant  equipment  ensures  microscope  focusing  and  full  slide  scanning,  and  determines
the above mentioned parameters excluding any unfilled spaces as vessels, sinusoids, bili‐
ary ducts and artifactual holes.  The system is able to identify and exclude the Glisson’s
capsule from the analysis. Colour thresholds are used to select the areas of interest.  The
inflammatory  cells  are  identified  by  immunohistochemical  visualisation  of  leukocyte
common antigen.  For the analysis,  the inflammatory cell  clusters are outlined by imagi‐
nary line connecting the centres  of  the outermost  cells;  after  that  the area of  clusters  is
measured. Thinking in the usual terms, the portal and periportal infiltrates are character‐
ised by this measurement; the portal fibrosis also can influence this measurement provid‐
ing homing space for inflammatory infiltrate. The area of extra-cluster inflammatory cells
is  measured  separately;  these  could  mostly  correspond  to  intralobular  infiltrate.  When
analysing fibrosis, area of fibrotic tissue is measured. The wrinkledness is detected as the
ratio  between  the  perimeter  and  area  of  an  object.  As  portal  field  in  healthy  liver  is
smooth, the concept of wrinkledness is an efficient way to detect periportal inflammation
and portal fibrosis. The irregularity of collagen islets necessitates the correction by fractal
dimension; the fibrotic foci  are considered truncated planar fractals.  The residual paren‐
chyma is characterised by the tissue area that is not occupied by inflammatory cells and
fibrosis. Finally, the loss of order is characterised mathematically. In order to characterise
the course of the disease in analogue with the usual staging, the individual fibrosis sca‐
lar is compared with the curve of fibrosis development over the course of disease detect‐
ing the percentage of the disease course before collagen deposition reaches the maximal
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tolerated  level  of  32%  [40]  or  approximately  36%  in  liver  cirrhosis  necessitating  liver
transplantation [24].  Thus,  three approaches are combined: the outlines of  regular struc‐
tures as vacuoles are characterised by traditional, non-fractal geometry, the area of fibro‐
sis  and  parenchyma  are  detected  using  the  traditional  measurements  corrected  by  the
fractal dimension, and the tectonic index is based on the relationships between the Eucli‐
dean and fractal dimensions of liver tissue. One of the many positive features of this sys‐
tem is  the  ability  to  generate  continuous  scalar  variables.  When analysing  dynamics  in
repeated liver biopsies by scalar data, naturally, less biopsies are characterised as lacking
significant changes.
Although fractal concept is used in medicine, including at least microscopy, neuroscience
and ophthalmology as well as automated measurements not limited to pathology [49, 51,
52], the study described in reference [40] is remarkable as it is highly sophisticated and prac‐
tical; it is understandable that the research group considers their machine as an intelligent
collaborator – and this is exactly the way how future biopsy analysis should proceed.
7. Functional liver tissue analysis in biopsy
The  diagnostic  evaluation  of  liver  biopsy  is  mostly  based  on  panel  of  histochemical
stains  including  hematoxylin-eosin  [2],  Masson’s  trichrome  [3],  PAS  [5]  and  Perl’s  [1]
stains  as  well  as  others  by  necessity.  These  visualisation  techniques  should  be  comple‐
mented by various “-  omics” tools [27]  to gain more data on the function of liver cells.
The  cytokines,  inflammatory  mediators,  viral  proteins,  cell  cycle  proteins  and apoptosis
markers  can  be  detected;  metabolic  pathways  can  be  investigated  as  well.  At  present,
most  or proteomic and genetic  studies are carried out for scientific  research in order to
outline the pathogenesis of different diseases. However, in future it could be advisable to
include such studies with validated value in the routine investigation as technically the
amount of tissue in liver biopsy is sufficient.
Cytokine expression can be analysed, e.g., TGF, EGFR and others [25]. When studying inter‐
leukin-6 (IL-6) expression in liver biopsies, higher IL-6 expression was found in non-alcohol‐
ic steatohepatitis than in steatosis. Correlation between IL-6 expression and degree of
inflammation and stage of fibrosis was detected as well [53]. Due to the complex nature of
cytokine action, wide spectrum of different molecules and their receptors must be analysed
in details in order to avoid insignificant or contradictory results. This leads to a clear-cut ne‐
cessity for virtual microscopy and digital image analysis. Toll-like receptor-4 (TLR4) expres‐
sion can be analysed in liver biopsy by immunohistochemistry. The expression of TLR4 has
been shown in hepatic progenitor cells and interlobular bile duct epithelium in correlation
with stage of liver disease, grade of liver inflammation and activity of portal/septal myofi‐
broblasts [54]. The expression of interferon stimulated gene 15 can be analysed by IHC at
protein level; up-regulation in hepatocytes is more pronounced in patients not responding
to interferon / ribavirin treatment in contrast to predominant expression in Kuppfer cells in
treatment responders [55]. Proteomic studies including immunohistochemistry in liver biop‐
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sy have targeted cell structure-associated proteins - actin, tropomyosin, transgelin and hu‐
man microfibril-associated protein 4 in order to identify biomarkers of liver cirrhosis [56].
COX-2 is over-expressed in chronic hepatitis C and the expression decreases following treat‐
ment with interferon alpha regardless of sustained virological response [57]. Increased en‐
doglin and TGF beta 1 expression is significantly associated with progressive hepatic
fibrosis in chronic viral hepatitis C [58].
Cell cycle analysis can add valuable information [59]; digital image analysis should be add‐
ed in the logistics again. Arrested cell cycle status has been demonstrated in chronic hepati‐
tis C infection analysing the expression of mini-chromosome maintenance protein-2 as
higher sensitivity proliferation marker, G1 phase marker cyclin D1, S phase marker cyclin A,
cell cycle regulators p21 and p53, apoptotic protein caspase 3 and anti-apoptotic protein
Bcl-2 [60, 61]. When analysing liver biopsies from patients with chronic viral hepatitis C,
higher G1 and lower S phase fractions has been found also by Werling et al., employing im‐
age analysis method [59]. Apoptosis-related pathways can be explorated including evalua‐
tion of Bax, Bcl-xL and Bcl-2 proteins [62]. Thus, hepatitis C virus infection can deregulate
the cellular processes [63] and it can be practical to reveal the way and degree of the regula‐
tory shift.
Viral antigens including hepatitis C antigen can be detected in liver tissue by immunohisto‐
chemistry [64]; the finding can be helpful in cases with difficult differential diagnosis or
combined liver pathology. The association of expression pattern with fibrosis may suggest
pathogenetically important information as well [64].
Metabolic pathways can be evaluated in liver biopsy. For instance, widespread expression of
vitamin D receptor has been shown in the hepatocytes and inflammatory cells in case of
chronic liver disease including non-alcoholic steatohepatitis and chronic viral hepatitis C.
The expression decreases as the liver histology is damaged [65].
Inflammatory cells are as important components in diffuse liver disease as the hepatocytes.
Thus, higher numbers of intrahepatic follicular T-helper lymphocytes in conjunction with
IL28B polymorphism analysis is found to be strongly predictive of treatment response using
pegylated interferon and ribavirin [66]. CD4+ regulatory T cells can be evaluated [67].
Logistic structures have been implemented to develop next generation toolkits for automat‐
ed image analysis to enable quantification of molecular markers. The group of researchers
[27] have collaborated within open source image analysis project [68] to reach effective out‐
put by combination of quantitative analysis, multiplex quantum dot (nanoparticle) staining
and high resolution whole slide imaging to detect nine different fluorescent signals for mul‐
tiple antigens [27].
DNA microarray technology has enabled genome-wide analysis of gene transcript levels.
This technology has been applied in order to compare gene expression profiles at different
stages of chronic hepatitis C and hepatocellular carcinoma in the setting of hepatitis virus C
infection [63, 69]. Hundreds of genes involved in carcinogenesis, cell growth, proliferation
and death are differently expressed in advanced viral hepatitis C in comparison to early vi‐
ral hepatitis C or non-viral hepatitis [63]. In chronic hepatitis C, the up-regulation involves
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genes related to metabolism and immune responses. In hepatocellular carcinoma arising in
hepatitis C patients, genes associated with cell cycle, growth, proliferation and apoptosis are
up-regulated [69]. Chronic hepatitis B and autoimmune liver disease have been studied by
this technology as well [70]. In advanced chronic viral hepatitis B, genes associated with ex‐
tracellular matrix turnover, cell growth and DNA repair are up-regulated but the expression
of genes regulating complement activation and innate immune response is decreased. In
early disease stages, the gene expression is different in case of chronic viral hepatitis B, auto‐
immune hepatitis and primary biliary cirrhosis. Chronic viral hepatitis B is associated with
expression of genes considering chemotaxis and cell homeostasis; autoimmune hepatitis –
with down-regulation of genes associated with protein binding, but primary biliary cirrhosis
in early stages involves the actin and myosin gene expression. As chronic viral hepatitis B
progresses, the expression of genes regarding signalling pathway, cell communication, col‐
lagen turnover, chemokine ligands and metallothionein changes [70]. The findings are of
major interest displaying the pathogenesis of different inflammatory liver diseases and neo‐
plastic transformation. Diagnostic consequences should follow soon as the differential diag‐
nosis of inflammatory liver diseases regarding aetiology can represent a difficult task.
The level of mRNA can be post-transciptionally regulated by micro RNA (miRNA). The reg‐
ulation of biological processes by miRNA is shown also in case of such canonical diffuse liv‐
er disease as chronic viral hepatitis C. Technological studies have been conducted using
biopsy material [71]. Transcriptome analysis has shown prognostic value, e.g., in order to
predict the severity of fibrosis progression after liver transplantation in recurrent viral hepa‐
titis C patients [72].
8. Conclusions
Liver biopsy investigation could soon shift from routine light microscopy to digital image
analysis by virtual microscopy and incorporation of numerical measurements in conjunction
with integrated analysis of cell functions at DNA, RNA, protein and signalling level. This
shift could lead from static to dynamic tissue evaluation. The technological logistics should
include the best standards of tissue fixation, processing, microtomy and visualisation com‐
plemented by automated immunostaining, full slide scanning to ensure complete digital
analysis and optimal choice of software considering the biological appropriateness of the
analysis algorithm.
As the diagnostic electron microscopy is continually developing, we expect that in future it
will be used in hepatology as an auxiliary method, based on digital analysis of electrono‐
grams. Liver biopsy analysis using transmission and scanning electron microscope could
continue to provide important additional information in diagnostic hepatology and scientif‐
ic research of liver diseases, as well as it could help to study unresolved molecular mecha‐
nisms regulating liver cells’ functions. In future the ultrastructural studies of liver biopsy in
hepatology will probably be associated with assessment of liver tissues in cases of liver
transplantation, with studies of new medicinal products – detection or exclusion of their po‐
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tential hepatotoxic effect, with identification of viruses, as well as with determination of in‐
fluence of various environmental hazards.
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